Tag: neuroendocrine tumors

Society of Nuclear Medicine Patient Program June 2013

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE
Excel Diagnostics logo_2

Excel Diagnostics and Nuclear Oncology Center Selected For New Investigational PRRT Treatment and Gallium Scan for Carcinoid and Neuroendocrine Tumor Patients

May 15, 2013

For carcinoid, pancreatic neuroendocrine tumor, and other NET cancer patients seeking the most advanced nuclear medicine opportunities in  the United States, Excel Diagnostics and Nuclear Oncology Center  in Houston, Texas, in collaboration with…

READ MORE
Matthew Kulke, MD

New OncLive TV Series Focuses on Neuroendocrine Tumors

March 24, 2013

Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …

READ MORE
Louisiana Charity Contest

Carcinoid Research Fund — Please Vote for Louisiana State University Health Science Center Foundation (LSUHSC)

February 19, 2013

Your vote is needed to further carcinoid research!  Ten local charities will be awarded $50,000 by the Gulf Coast Bank through its Community Rewards program.  The LSUHSC Foundation — Carcinoid Research Fund (the NOLA Dream Team!) is one of the charities…

READ MORE
Vanderbilt Ingram Cancer Center 2

Unique Lung Carcinoid Conference to Feature European and American Physicians

February 5, 2013

When Dr. Dan Granberg, a leading carcinoid and neuroendocrine cancer specialist at Uppsala University in Sweden, joins Dr. Eric H. Liu, Director of the Neuroendocrine Tumor Center at Vanderbilt University Medical Center in Nashville, Tennessee, …

READ MORE
Celia M. Divino, MD

Luncheon with the Experts — Carcinoid and Neuroendocrine Tumor Patients Are Invited!!

January 4, 2013

The Big Apple Noids support group has initiated and is sponsoring, in collaboration with the Carcinoid Cancer Foundation, Luncheon with the Experts, a program which brings together carcinoid and neuroendocrine tumor (NET) patients with physicians…

READ MORE
Proclamation Map, 35 states, Nov 13, 2012

Happy New Year from the Carcinoid Cancer Foundation

December 28, 2012

As 2012 draws to a close, the Carcinoid Cancer Foundation would like to thank each of you for your support.  This year has been especially exciting because of our work on the Worldwide NET Cancer Awareness Day Alliance, with Grace Goldstein, CCF’s Chief…

READ MORE
Pablo Lapuerta, MD

Lexicon Pharmaceuticals Begins Phase 3 Clinical Trial of Telotristat Etiprate in Patients with Carcinoid Syndrome

December 4, 2012

Patients with metastatic carcinoid syndrome will have the opportunity to participate in a new Phase 3 clinical trial of Lexicon Pharmaceutical’s telotristat etiprate (LX1032), an oral drug candidate designed to treat carcinoid syndrome by reducing…

READ MORE
Giving Tuesday

Carcinoid Cancer Foundation Participates in #GivingTuesday

November 26, 2012

Help launch #GivingTuesday™!!  The Carcinoid Cancer Foundation is proud to participate in the first annual #GivingTuesday™ to be held on Tuesday, November 27, 2102. Charities, families, businesses and individuals are coming together to transform…

READ MORE
Eric Liu, MD, Vanderbilt University & patient

Neuroendocrine Tumor Webinar Just Opened to Patients and the Public

August 21, 2012

Just opened to the patient community and the public, with limited space available, is a free live webinar featuring carcinoid and NET cancer specialist Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville,…

READ MORE